MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

 
Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
 


Oncimmune buys back EarlyCDT distribution rights for China

StockMarketWire.com

Immunodiagnostics group Oncimmune said it had agreed to acquire the intellectual property and distribution rights for its lung-cancer diagnostics technology in China from Genostics Company.

Oncimmune said the move would allow it to pursue an optimum route to market in an important territory.

It had granted Genostics the exclusive rights to its EarlyCDT products. All material, IP, data, and goodwill would now be transferred back to Oncimmune, which would be be paid in full for royalties due in January 2021 under an existing technology licencing agreement.

In consideration, Oncimmune said it had agreed to pay a fixed amount for the return of the IP and distribution rights, with the majority of the value of the consideration being conditional on fixed future events.

At 9:25am: (LON:ONC) Oncimmune Holdings Plc share price was 0p at 177.5p


Story provided by StockMarketWire.com